Elevance Health Inc. beat EPS estimates 88% of the time across 16 reported quarters (14 beats, 2 misses), averaging +4.5% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $6.18 | $7.45 | +20.6% | Beat | Q2 FY26 call |
| Q1 FY26 | $10.68 | $12.58 | +17.8% | Beat | Q1 FY26 call |
| Q4 FY25 | $3.10 | $3.33 | +7.4% | Beat | Q4 FY25 call |
| Q3 FY25 | $4.98 | $6.03 | +21.1% | Beat | Q3 FY25 call |
| Q2 FY25 | $9.16 | $8.84 | -3.5% | Miss | Q2 FY25 call |
| Q1 FY25 | $11.97 | $11.97 | +0.0% | Beat | Q1 FY25 call |
| Q4 FY24 | $3.80 | $3.84 | +1.1% | Beat | |
| Q3 FY24 | $9.70 | $8.37 | -13.7% | Miss | |
| Q2 FY24 | $9.99 | $10.12 | +1.3% | Beat | |
| Q1 FY24 | $10.54 | $10.64 | +0.9% | Beat | |
| Q4 FY23 | $5.55 | $5.62 | +1.3% | Beat | |
| Q3 FY23 | $8.45 | $8.99 | +6.4% | Beat |
Back to ELV overview · ELV holders · ELV KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.